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Background: Boswellia dalzielii is a widely used medicinal plant in African traditional medicine. The efficacy of its 
stem bark extract in management of convulsions is well acclaimed among communities of Northern Nigeria. 
Objective: To evaluate the anticonvulsant potentials of methanol stem bark extract of Boswellia dalzielii in mice and 
chicks. 
Methodology: Phytochemical screening, elemental analysis and acute toxicity studies was carried out. The extract 
was evaluated for anticonvulsant activity against electrically-induced seizures in chicks and against 
pentylenetetrazole, strychnine, picrotoxin and 4-aminopyridine-induced seizures in mice at doses of 20, 40 and 80 
mg/kg. 
Results: The intraperitoneal LD50 was estimated to be 280 and 570 mg/kg in mice and chicks respectively. The extract 
at 20 mg/kg provided 40% protection and significantly (p<0.05) increased the mean onset of seizure in MEST. A dose-
dependent and significant (p<0.05) increase in the mean onsets of pentylenetetrazole and strychnine-induced 
seizures were produced by the extract at 80 mg/kg. Similarly, a dose-dependent and significant increase (p<0.05 and 
p<0.01) in latency to picrotoxin-induced convulsions was observed at 40 and 80 mg/kg respectively. 
Conclusion: These findings suggests the methanol stem bark extract of Boswellia dalzielii possesses anticonvulsant 
activities and thus supports the ethnomedical rationale for its use against convulsions. 
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1. Introduction 
Epilepsy is one of the most common neurological 
disorders affecting people of all ages, race and social 
class; and imposing significant economic implications in 
terms of health care needs, premature death and loss of 
work productivity (WHO 2017). There are an estimated 
50 million people with epilepsy globally, of which 75-
80% of such people live in low and middle-income 
countries with little or no access to medical services or 
treatment (Ngugi et al, 2010; WHO 2017). The 
prevalence of epilepsy in Nigeria is about 6.2 per 1000 
(Banerjee et al, 2009). Although several anticonvulsants 
are used in management of epilepsy, 30% of epileptic 
patients do not have seizure control even with the best 
anticonvulsants (Yemitan and Adeyemi, 2013). The use 
of such drugs are associated with not only drug 
interactions but also debilitating adverse reactions 
including allergies, sedation, blood dyscrasias, 
teratogenesis, changes in mood and memory problems 
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(Loscher, 2002; Johannessen Landmark and Patsalos, 
2010). Therefore, development of new, affordable and 
accessible pharmacological agents with better safety 
and efficacy profiles has become paramount in epilepsy 
research (Yaro et al, 2015).  
Natural products have remained the keystone in drug 
discovery and will still maintain an important role in 
this area in the future (Newman and Cragg, 2012, 
Malami et al, 2016). Many medicinal plants are known 
for their anticonvulsant activity and their extracts can 
be important source of chemicals for the development 
of better and safer drugs for the treatment of epilepsy 
(Quintans Junior et al, 2008; Kumar et al, 2012). 
Similarly, the use of herbal medicine in the management 
of epilepsy is widely accepted in most communities in 
Nigeria and their efficacies are well acclaimed. Some of 
these plants remain to be investigated for their value as 
sources of antiepileptic drugs and therefore, research is 
needed to validate the folkloric claims of these 
medicinal plants so as to provide scientific evidence of 
their safety and efficacy.     
Boswellia dalzielii Hutch. is a member of Burseraceae 
family, a tree that grows up to 13 meters high with a 
characteristic ragged pale papery bark. It is locally 
abundant from Northern Ivory Coast to Northern 
Nigeria and into Cameroun and Central African 
Republic. It is commonly known as frankincense tree 
and vernacular names include “Hano” (Hausa) and 
“Andakehi” (Fulfulde) (Burkill, 1985). In Northern 
Nigeria, the bark has common applications in treating 
fever, arthritis, rheumatism and gastro-intestinal 
problems. The fresh bark is used as an emetic and to 
relieve symptoms of giddiness and palpitations (Burkill, 
1985). Decoction of the stem bark is also used as 
tranquillizer, in the treatment of convulsions and 
mental derangement (Ibrahim et al, 2007). To the best 
of our search, there is no report on the anticonvulsant 
activity of Boswellia dalzielii stem bark in literature and 
this study therefore was aimed at evaluating its 
anticonvulsant activity using animal models of epilepsy. 
2. Materials and Methods 
2.1  Test drugs and chemicals 
Pentylenetetrazole, Strychnine, Picrotoxin (Sigma 
Chemical Co., USA) and 4-aminopyridine (Merck-
Schuchardt, Germany) were used for the induction of 
seizure in the experimental animals. Standard drugs 
used were Phenytoin sodium (Parker-Davis and Co Ltd. 
Detroit), Phenobarbitone (Lab Renaudin, France) and 
Sodium Valproate (Sanofi-aventis, UK). Solvents used 
include Methanol, Petroleum ether, Chloroform and 
Ethyl acetate (Sigma Chemical Co., USA).  
2.2 Animals 
Albino mice (18-24 g) of either sex obtained from the 
Animal House of the Department of Pharmacology and 
Therapeutics, Ahmadu Bello University, Zaria were used 
for the study. One-day old ranger cockerels (30-40 g) 
were obtained from the National Animal Production and 
Research Institute, Shika, Zaria. The animals were 
maintained in a well-ventilated room under ambient 
temperature and fed on animal feeds (Feeds Masters, 
Ilorin) and water ad libitum. The experiments 
performed in this study followed the principles of 
laboratory animal use and care policy outlined by the 
ethical committee of Ahmadu Bello University. The 
experimental protocols were approved by the 
University Animal Ethics Committee with the approval 
number: DAC/IW-OT/013-13.  
2.3 Plant material 
The stem bark of Boswellia dalzielii was collected in 
March, 2013, from Galadimawa, Kaduna State, Nigeria. 
The plant was identified and authenticated by a 
taxonomist in the Herbarium Section of the Department 
of Biological Sciences, Ahmadu Bello University, Zaria, 
and a voucher specimen (Number 2448) was deposited 
for future reference.  
2.4 Preparation of the plant extract 
The stem bark was air dried under shade and then 
pulverized to coarse powder using pestle and mortar, of 
which 400 g was extracted with petroleum ether in a 
soxhlet apparatus. The marc was air dried and then re-
extracted to exhaustion with 800 ml of absolute 
methanol. The extract was then concentrated under 
reduced pressure to give solid residue and later stored 
in a dessicator until required in the main study. 
2.5 Phytochemical screening 
Thin layer chromatographic analysis of the extract was 
carried out using standard methods (Wagner and Bladt, 
1996). The solution of the extract was spotted on silica 
gel-coated thin layer chromatographic (TLC) plates (4 
cm×8 cm) and the plates were developed in a solvent 
system (Chloroform: Ethylacetate, 5:3). Each plate was 
sprayed with a specific visualizing reagent to screen for 
the presence of alkaloids, anthraquinones, cardiac 
glycosides, flavonoids, saponins and tannins.  
2.6 Elemental analysis 
The dried stem bark and methanol extract of Boswellia 
dalzielii were digested by wet digestion method. Briefly, 
0.5 g of each of the sample was weighed into a beaker 
and digested with 10 ml of concentrated nitric acid and 
concentrated hydrochloric acid in the ratio 3:1 at 200°C. 
The solution was then filtered into a 50 ml volumetric 
flask and made up to the mark with distilled water. The 
digest was transferred to plastic bottles and later 
analyzed for the presence and levels of Magnesium, 
Copper, Calcium, Zinc, Nickel, Iron, Cadmium and 
Manganese using Varian AA240FS spectrophotometer 
following standard method (AOAC, 1995).  
2.7 Acute toxicity testing 
The intraperitoneal median lethal dose (LD50) was 
determined in mice and chicks (Lorke, 1983). The study 
was carried out in two phases. In the initial phase, three 
groups each containing three animals (mice or chicks) 
received the methanol stem bark extract at doses of 10, 
100 and 1000 mg/kg body weight and then observed 
for signs of toxicity and death within 24 hrs. In the 
second phase, four animals (mice or chicks) were 
treated with more specific doses (200, 400, 800 and 
1600 mg/kg) of the extract respectively and observed 
for signs of toxicity and death within 24 hours. The LD50 
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was calculated as the square root of the product of the 
lowest lethal dose and the highest non-lethal dose. 
2.8 Anticonvulsant studies 
Maximal electroshock induced convulsion test in 
chicks 
The methods of Swinyard and Kupferberg (1985) and of 
Browning (1992) were employed using fifty day-old 
cockerels which were divided into five groups of 10 
chicks each. The apparatus used was Ugo Basile 
Electroconvulsive Machine (Model 7801, Italy) 
connected to a stabilizer with corneal electrodes placed 
on the upper eyelids of the chicks. A day-old chick has 
an underdeveloped blood brain barrier, thereby 
facilitating easy passage of drugs and current into the 
brain. A current (80 mA) which induced tonic seizures 
in 90% of the control group of chicks was selected. The 
shock duration, frequency and pulse width was set at 
0.8 sec, 100 pulse/sec and 0.6 ms respectively, and was 
used throughout the study.  
The second group of chicks were pretreated with 20 
mg/kg of phenytoin, while the third, fourth and fifth 
groups were pretreated with 20, 40 and 80 mg/kg of 
the extract respectively all through the intraperitoneal 
route. Thirty minutes later, these chicks were subjected 
to maximum electroshock as in the control group. 
Seizures were manifested as hind limb tonic extension 
(HLTE). The ability to prevent this feature or prolong 
the latency and or onset of the HLTE was considered an 
indication of anticonvulsant activity (Swinyard, 1969).  
Pentylenetetrazole (PTZ)-induced convulsion test in 
mice 
The method of Swinyard et al, (1989) was employed. 
Thirty mice were divided into five groups of six mice 
each. The first group was pretreated with normal saline 
(10 ml/kg i.p.). The second, third and fourth groups 
were pretreated with 20, 40 and 80 mg/kg of the 
extract respectively, while the fifth group was 
pretreated with 200 mg/kg body weight of sodium 
valproate i.p. Thirty minutes later, mice in all the groups 
were injected with a convulsive dose of PTZ (90 mg/kg) 
subcutaneously and were observed for a period of thirty 
minutes. The absence of a clonic spasm of at least five 
seconds duration indicates the extract’s ability to 
abolish the effect of PTZ on seizure threshold.  
Strychnine-induced convulsion test in mice 
The method described by Porter et al, (1984) was 
employed. Thirty mice were divided into five groups of 
six mice each, with the first group was pretreated with 
normal saline (10 ml/kg i.p.). The second, third and 
fourth groups were pretreated with 20, 40 and 80 
mg/kg of the extract respectively while the fifth group 
received 20 mg/kg of phenobarbitone all through the 
i.p. route. Thirty minutes later, mice in all the groups 
were injected with a convulsive dose of strychnine (1.0 
mg/kg) subcutaneously. Abolition of tonic extension 
jerks of the hind limbs within 30 min after strychnine 
administration was considered as an indication of 
anticonvulsant activity. 
Picrotoxin-induced convulsion test in mice 
In this test, thirty mice were randomly divided into five 
groups containing six mice each. The first group served 
as negative control and was pretreated with normal 
saline 10 ml/kg. The second, third and fourth groups 
were pretreated with 20, 40 and 80 mg/kg of the 
extract respectively, while the fifth group was 
pretreated with 20 mg/kg phenobarbitone all through 
the intraperitoneal route. Thirty minutes post 
treatment all mice were treated with 4 mg/kg 
picrotoxin by subcutaneous route. Immediately after 
picrotoxin injection mice were observed for the 
following symptoms during the next 30 min: clonic 
seizures, tonic seizures and death (Vogel, 2008). 
4-aminopyridine (4-AP)-induced convulsion test in 
mice 
Thirty mice were randomly divided into 5 groups each 
containing six mice. The first group served as control 
and was pretreated with normal saline 10 ml/kg i.p. The 
second, third and fourth groups were pretreated with 
20, 40 and 80 mg/kg of the extract respectively, while 
the fifth group was pretreated with 20 mg/kg of 
phenobarbitone all through the intraperitoneal route. 
Thirty minutes post treatment 4-AP was administered 
at a dose of 14 mg/kg subcutaneously to each mouse. 
The mice were observed for 30 min for characteristic 
behavioural signs, such as hyperactivity, trembling, 
intermittent forelimb extension, tonic seizures and 
death. Ability of the extract to protect the mice from 
lethality within the 30 min observation period was 
considered as an indication of anticonvulsant activity 
(Yamagachi and Rogawski, 1992). 
2.9 Statistical analysis 
Data were expressed as percentages and as mean ± 
standard error of mean (S.E.M.). Difference between 
means was analyzed by one way analysis of variance 
(ANOVA); when statistical significance was obtained 
with ANOVA, Dunnett’s post hoc test was performed. 
Values of p< 0.05 were considered significant. 
3. Results  
Percentage yield of methanol stem bark extract of 
Boswellia dalzielii was 8.66% w/w. Thin layer 
chromatographic analysis revealed the presence of 
cardiac glycosides, flavonoids, saponins and tannins.  
The elements investigated were found in stem bark of 
Boswellia dalzielii with calcium occurring in the largest 
proportion (Table 1).  
Acute toxicity studies 
In the first phase of the study, two mice and two chicks 
died at 1000 mg/kg of the extract following respiratory 
depression. In the second phase of the study, the highest 
lethal dose was 400 mg/kg in mice; however, no death 
of chicks was recorded. The intraperitoneal LD50 of the 
crude stem bark extract of Boswellia dalzielii in mice 
and chicks was thus estimated to be 280 and 570 mg/kg 
respectively. 
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Table 1: Mineral content of the powdered stem bark and methanol stem bark extract of Boswellia dalzielii 
Elements Stem bark (ppm) Methanol extract (ppm) 
Magnesium 3.475 5.761 
Copper 0.020 0.102 
Calcium 56.294 32.505 
Zinc 0.360 0.382 
Nickel 0.026 0.158 
Iron 0.991 0.591 
Manganese 0.108 0.051 
      ppm = parts per million 
Effect of methanol stem bark extract of Boswellia 
dalzielii on electroshock-induced convulsions in 
chicks 
The extract at 20, 40 and 80 mg/kg protected 40%, 
10%, and 30% of chicks respectively against HLTE 
induced by the electroshock. This effect was not dose 
dependent. The extract at 20 mg/kg significantly 
(p<0.05) increased the mean onset of seizure compared 
to normal saline group.  
However, there was no significant difference in the 
mean recovery periods. The standard drug phenytoin 
provided 90% protection against HLTE (Table 2). 
Effect of methanol stem bark extract of Boswellia 
dalzielii on PTZ-induced convulsion in mice 
Boswellia dalzielii extract produced a dose dependent 
increase in the mean onset of seizures with significant 
difference (p<0.05) at 80 mg/kg compared to the saline 
control group. The 80 mg/kg also afforded 33.33% 
protection against seizures.  
The standard drug, sodium valproate provided 100% 
protection against PTZ-induced convulsion in mice 
(Table 3). 
 
Effect of methanol stem bark extract of Boswellia 
dalzielii on strychnine-induced seizures in mice 
Boswellia dalzielii extract provided 33.33 % protection 
against strychnine-induced seizure at 40 mg/kg while at 
20 and 80 mg/kg, 16.67 % protection was provided. 
The extract also significantly (p< 0.05) increased the 
latency of convulsion at 20 and 80 mg/kg compared to 
control group. The standard drug, phenobarbitone 
produced 83.33% protection against seizures (Table 4).   
Effect of methanol stem bark extract of Boswellia 
dalzielii on picrotoxin-induced seizures in mice  
The extract at 40 mg/kg protected 50% of the mice 
against picrotoxin induced convulsion. It also produced 
a dose dependent increase in latency to convulsions 
with significant difference (p<0.05) at 40 mg/kg and 
p<0.01 at 80 mg/kg compared to the saline control 
group. The standard drug, phenobarbitone produced 
100% protection (Table 5). 
Effect of methanol stem bark extract of Boswellia 
dalzielii on 4-AP-induced convulsion in mice  
The extract had no effect against 4-AP-induced seizures. 
However, the standard drug phenobarbitone provided 
100% protection against seizure (Table 6). 
 
Table 2: Effect of methanol stem bark extract of Boswellia dalzielii on electroshock-induced convulsion in chicks 
Treatment 
(mg/kg) 
Mean onset of 
seizures (sec) 






NS           10 ml/kg 4.63 ± 0.28 6.11 ± 0.70 1/10 10.00 
MEBD     20  7.03 ± 1.04* 5.00 ± 0.37 4/10 40.00 
MEBD     40  4.32 ± 0.18 5.56 ± 0.58 1/10 10.00 
MEBD     80  4.17 ± 0.42 5.57 ± 0.65 3/10 30.00 
PH           20  5.75 ± 0.00 4.00 ± 0.00 9/10 90.00 
Values are Mean ± S.E.M., n=10, * denotes significant difference from normal saline group F {(3, 27) = 6.15; p< 0.05} - One way 
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Table 3: Effect of methanol stem bark extract of Boswellia dalzielii on PTZ-induced convulsions in mice 
Treatment (mg/kg) Mean onset of seizures (min) Quantal protection 
% Protection 
against seizure 
NS             10 ml/kg 05.00 ± 0.73 0/6 0.00 
MEBD       20  06.00 ± 1.79 1/6 16.67 
MEBD       40  09.50 ± 2.01 0/6 0.00 
MEBD       80  10.75 ± 2.01* 2/6 33.33 
SV             200 – 6/6 100.00 
Values are Mean ± S.E.M., n=6, * denotes significant difference from normal saline group F {(3, 17) = 2.59; p< 0.05} - One way 
ANOVA followed by Dunnett’s test, NS= Normal Saline, MEBD=Methanol stem bark extract of Boswellia dalzielii, SV=Sodium 
valproate 
 
Table 4: Effect of methanol stem bark extract of Boswellia dalzielii on strychnine-induced convulsions in mice 
Treatment (mg/kg) Mean onset of seizures (min) Quantal protection 
% Protection 
against seizure 
NS            10 ml/kg 06.33 ± 0.49 0/6 0.00 
MEBD      20  13.00 ± 2.02* 1/6 16.67 
MEBD      40  10.00 ± 1.35 2/6 33.33 
MEBD      80  10.60 ± 0.75* 1/6 16.67 
PBT          20 21.00 ± 0.00* 5/6 83.33 
Values are Mean ± S.E.M., n=6, * denotes significant difference from normal saline group F {(3, 16) = 5.51; p< 0.05} - One way 
ANOVA followed by Dunnett’s test, n=6, NS-Normal Saline, MEBD- Methanol stem bark extract of Boswellia dalzielii, PBT- 
Phenobarbitone 
 
Table 5: Effect of methanol stem bark extract of Boswellia dalzielii on picrotoxin-induced convulsions in mice 
Treatment (mg/kg) Mean onset of seizures (min) Quantal protection 
% Protection 
against seizure 
NS           10 ml/kg 11.50 ± 0.56 0/6 0.00 
MEBD     20  15.67 ± 1.02 0/6 0.00 
MEBD     40  19.00 ± 4.00* 3/6 50.00 
MEBD     80  20.50 ± 1.59** 0/6 0.00 
PBT         20 − 6/6 100.00 
Values are Mean ± S.E.M., n=6, significant difference from normal saline group F {(3, 17) = 7.16, MEBD 40 mg/kg *p< 0.05, 
MEBD 80 mg/kg **p< 0.01} - One way ANOVA followed by Dunnett’s test, NS=Normal Saline, MEBD=Methanol stem bark 
extract of Boswellia dalzielii, PBT= Phenobarbitone 
 
Table 6: Effect of methanol stem bark extract of Boswellia dalzielii on 4-aminopyridine-induced convulsions in mice 
Treatment (mg/kg) Mean onset of seizures (min) Quantal protection 
% Protection 
against seizure 
NS            10 ml/kg 12.17 ± 1.01 0/6 0.00 
MEBD      20 16.60 ± 1.81 1/6 16.67 
MEBD      40 12.67 ± 2.51 0/6 0.00 
MEBD      80 16.83 ± 2.02 0/6 0.00 
PBT          20 − 6/6 100.00 
Values are mean ± S.E.M., n=6, no significant difference F {(3, 19) = 1.67} - One way ANOVA, NS = normal saline, MEBD = 
methanol stem bark extract of Boswellia dalzielii, PBT = Phenobarbitone  
4.0 Discussion 
Phytochemical analysis of the stem bark extract of 
Boswellia dalzielii revealed the presence of 
phytochemical constituents known to be responsible for 
different pharmacologic activities. Flavonoids and 
saponins for example have been reported to possess 
anticonvulsant activity (Kavvadias et al, 2004). Thus, 
the anticonvulsant activities of the stem bark extract of 
Boswellia dalzielii may be due to the presence of 
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flavonoids and saponins among other 
phytoconstituents.  
Trace elements like manganese, copper and zinc are 
essential micronutrients and have a variety of 
biochemical functions. Calcium for example, is an 
essential macro element required for critical biological 
functions such as nerve conduction, muscle contraction, 
cell adhesiveness, mitosis, blood coagulation and 
structural support of the skeleton (Miller et al, 2001). 
Hypocalcaemia has been reported to be responsible for 
20 to 34% of convulsions especially in children 
(Cockburn et al, 1973). Studies by Roberton and Smith, 
(1975) on early neonatal hypocalcaemia had shown 
that infants who developed clonic convulsions 
simultaneously with the hypocalcaemia did not develop 
further convulsions after oral calcium supplements had 
raised the serum calcium to normal. It is plausible the 
calcium content of Boswellia dalzielii had played a role 
in the anticonvulsant activities observed. 
The acute toxicity studies suggest that the methanol 
stem bark extract of Boswellia dalzielii is moderately 
toxic in mice following intraperitoneal administration 
according to classification by Corbett et al, (1984). The 
doses of the extract used in this study were lower than 
30% of the LD50. These doses are relatively safe for 
ethnopharmacological research (Vongtau et al, 2004). 
Boswellia dalzielii extract showed weak protection 
against maximal electroshock test (MEST). MEST is a 
standard anti-epileptic drug (AED) test that evaluates 
the testing material’s ability to protect against HLTE 
phase of the MEST (DeLorenzo et al, 2001; Magaji et al, 
2013; Nazifi et al, 2015). Such protection projects 
anticonvulsant activity of AEDs that prevent the spread 
of the epileptic seizure discharge from an epileptic focus 
during seizure activity (Raza et al, 2001). Ability of the 
extract to significantly prolong the mean onset of 
seizure and protect the chicks against MEST suggests 
that it might possess compounds with ability to abolish 
seizure spread. This further suggests that it may be of 
value in the treatment of generalized tonic clonic and 
partial seizures.   
PTZ is a known convulsant and anticonvulsant activity 
in PTZ test identifies compounds that can raise the 
seizure threshold in the brain (White et al, 1998). PTZ 
has been shown to interfere with GABA 
neurotransmitter and the GABA receptor complex (Bum 
et al, 2001). Antagonism of PTZ induced seizure 
suggests potentiating effect on GABAergic 
neurotransmission. Standard antiepileptic drugs like 
phenobarbitone, sodium valproate and benzodiazepines 
produce a dose dependent suppression of PTZ-induced 
seizure (McNamara, 2006). The dose dependent 
increase in the latency of seizures by the extract against 
threshold seizure induced by PTZ suggests the presence 
of bioactive compounds that could be effective in the 
therapy of absence or myoclonic seizures.  
The convulsive action of strychnine is due to its ability 
to inhibit spinal reflexes of glycine (Sayin et al, 1993) 
which is an important inhibitory transmitter to motor 
neurons and interneurons in the spinal cord. Strychnine 
sensitive postsynaptic inhibition in higher centers of the 
central nervous system is also mediated by glycine. The 
significant increase in the latency of strychnine-induced 
seizure by the extract may therefore be due to glycine 
inhibitory potentiation mechanisms. This suggests that 
the extract may contain compounds that interact with 
the glycine receptors probably as agonists or enhancing 
the binding of glycine to its receptors.    
Picrotoxin has been reported to cause convulsion by 
blocking GABAA receptor-linked chloride ion 
conductance into the brain cells (Leonard, 2000; Nicoll, 
2001). The fact that the extract of Boswellia dalzielii 
protected animals against picrotoxin-induced 
convulsion further suggests that the plant extract 
contains compound(s) that facilitate GABA 
transmission.  
4-aminopyridine is a known potassium channel blocker 
that interferes with all aspect of neuronal excitability, 
including resting membrane potential, responsiveness 
to synaptic inputs, frequency adaptation and 
neurotransmitters release (Wickenden, 2002). Drugs 
like phenytoin, which block seizure spread are effective 
antagonists of seizures induced by K+ channel blockade, 
while those with specific actions on other cellular 
targets may be weak or inactive, presumably because 
they are unable to attenuate the spread of intense (non-
NMDA receptor mediated) excitation evoked by 4-
aminopyridine (Yamaguchi and Rogawski, 1992). The 
absence of anticonvulsant activity against 4-
aminopyridine-induced seizures suggests Boswellia 
dalzielii extract may not be interacting with potassium 
channels in producing its anticonvulsant activity. 
5.0 Conclusion  
The results obtained suggests the methanol stem bark 
extract of Boswellia dalzielii contains bioactive 
components with potential anticonvulsant properties, 
thus supporting its ethnomedicinal use in the treatment 
of convulsions. 
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